Scaled-up radiolabelling of DOTATATE with 68Ga eluted from a SnO2-based 68Ge/68Ga generator

https://doi.org/10.1016/j.apradiso.2011.07.016Get rights and content

Abstract

A scaled-up radiolabelling and improved post-labelling purification procedure for [68Ga]DOTATATE is reported, using a more than 1 year old SnO2-based 1850 MBq 68Ge/68Ga generator (initially double-loaded with 3700 MBq 68Ge) as a source of ionic 68Ga. The elution method of choice comprised elution with 0.6 M HCl in a single 4 mL fraction, containing up to 95% of the total eluted 68Ga activity. The unpurified fraction was directly used for labelling after pH adjustment with 2.5 M sodium acetate. Labelling efficiencies were determined at 90–95 °C at various reaction times and reaction volumes of up to 5.7 mL, using either 30 μg or 50 μg DOTATATE. Only the latter amount resulted in consistently high labelling efficiency in excess of 95%. Post-labelling purification, carried out on Sep-Pak C18, showed that 50% ethanol in saline was a superior desorption eluant than 100% ethanol. The highest and most consistent decay-corrected radiochemical yields (89%) were obtained using 50 μg DOTATATE and a 20 min reaction time.

Highlights

68Ga-labelling of DOTATATE with SnO2-based 68Ge/68Ga generator eluates was examined. ► pH of the non-concentrated/unpurified eluates was adjusted with 2.5 M NaOAc. ► Consistently good labelling results were obtained with 50 μg DOTATATE in 5.6 mL. ► Better Sep-Pak C18 product desorption eluant was 50 % ethanol in saline. ► Described methodology delivers nearly 90% decay-corrected radiochemical yields.

Introduction

The diagnostic applications of 68Ga-labelled DOTA-conjugated peptides for positron emission tomography (PET) in oncology have been well documented (Hofmann et al., 2001, Henze et al., 2001, Meyer et al., 2003a, Meyer et al., 2004, Maecke et al., 2005, Breeman et al., 2005). The somatostatin analogue DOTA-D-Phe1–Tyr3-Octreotide (DOTATOC) appears to be the gold standard for 68Ga-based PET peptide radiopharmaceuticals (Maecke et al., 2005), but DOTATATE, in which the terminal Thr(ol) amino acid of DOTATOC is replaced with a Thr unit, has also become an important peptide analogue for clinical application (Fani et al., 2008).

The 68Ge/68Ga generator has become a well established and reliable source of 68Ga, making the latter completely cyclotron-independent and routinely available. Various sorbent materials for such generators have been documented over the years, such as organic anion exchange resins (Neirinckx and Davis, 1980), and more recently, composite sorbents such as nanoceria-polyacrylonitrile (Chakravarty et al., 2010). The most commonly used commercially available 68Ge/68Ga generator in the recent times has been based on a TiO2 solid support (Zhernosekov et al., 2007). Recently, a SnO2-based generator, produced by iThemba LABS, South Africa, has also become commercially available and its characteristics have been described in a paper by De Blois et al. (2011). In order to achieve optimal elution efficiencies with this generator, it has to be eluted with a more acidic eluant (0.6 M HCl) as opposed to the 0.1 M HCl required for the TiO2-based generator. DOTA-peptide labelling is conducted at pH values between 3 and 5 (Meyer et al., 2003a, Meyer et al., 2004, Breeman et al., 2005). Therefore, when more acidic 68Ga-containing eluates are used in peptide labelling, labelling recipes need to be adapted.

Due to the presence of metal contaminants in 68Ga solutions that could interfere with labelling, as well as the possible breakthrough of 68Ge from generators, the pre-purification of eluates has become an important part of peptide labelling systems (Meyer et al., 2003a, Meyer et al., 2003b, Meyer et al., 2004, Zhernosekov et al., 2005, Zhernosekov et al., 2007). Another advantage of the pre-purification process is the volume reduction of 68Ga solutions, as the labelling at nanomolar peptide concentration levels requires small reaction volumes to maximise labelling yields (Meyer et al., 2003a, Meyer et al., 2004, Zhernosekov et al., 2007). Various concentration methods have been described, such as anion (Meyer et al., 2003b, Meyer et al., 2004, Velikyan et al., 2008) and cation (Zhernosekov et al., 2005, Zhernosekov et al., 2007) exchange chromatography. Each of these methods has its advantages and disadvantages; however, the design of labelling systems could become complicated when such pre-purification devices are incorporated into a system. The use of merely a post-labelling purification device, such as a solid phase C18 cartridge, could probably be a more practical option, provided that de-sorption yields are optimised. Concerns about possible complexation of the four-valent radionuclidic impurity 68Ge by DOTA-conjugated ligands, regardless the chemical form in which Ge exists, are unjustified. It has been reported that the DOTA moiety forms stable complexes with several 2+ and 3+ charged metals only (Meyer et al., 2004, Heppeler et al., 1999). Furthermore, it has been reported that four-valent metals such as Zr4+ and Hf4+ are not competitors for the incorporation of trivalent cations such as In3+, Y3+ and Lu3+ into DOTA (Breeman et al., 2003). Literature reports that C18 purification reduces the 68Ge content of labelling mixtures more than 100-fold (Decristoforo et al., 2007) and give further impetus to our statement. Another technique to overcome problems associated with voluminous eluates is their fractionation (Breeman et al., 2005), in which the generator is eluted in such a way that the maximum amount of activity is recovered in the smallest possible volume. This technique, however, might result in the over-complication of labelling systems and/or loss of usable activity in un-used fractions.

With all these in mind, we embarked on a study to develop a simple, practical method to prepare 68Ga-labelled DOTATATE on a relatively large scale, using partially fractionated, unpurified 68Ga eluates obtained from a SnO2-based generator. In order to accomplish this, we set out the following objectives: to maximise the amount of eluted activity available for the labelling process, to adapt existing labelling recipes in order to accommodate a more acidic eluate and to scale up labelling reactions at the same time without compromising radiochemical yields, to optimise reaction time in order to achieve optimal effective yields and to improve existing solid phase C18 purification techniques in order to optimise recovery yields and to bring about an injection-ready post-purified product.

Section snippets

Generator elution

A SnO2-based 1850 MBq 68Ga generator (double-loaded with 3700 MBq 68Ge) was prepared in house at iThemba LABS, South Africa. It was equipped with inlet and outlet polyethylene tubes with terminal Luer fittings, joined together with a 3 way stopcock valve. Elution was carried out with 0.6 M HCl (prepared from 30% Suprapure Hydrochloric acid from Merck) up to a total of approximately 10 mL at a time. During the first 12 months since its assembly it had been eluted about 4–5 times a week, and the

Generator elution

Fig. 1 shows a roughly composed elution profile of 68Ga activity eluted from a 1 year old double-loaded 1850 MBq tin dioxide-based generator. As a result of the double-loaded characteristic of the generator, activities in excess of 600 MBq could still be eluted after a period of one year since its assembly. After 18 months this amount dropped to approximately 350 MBq. Elution method 1 yielded a main fraction comprising 75–80% of the total eluted activity in a volume range of 2.4–2.8 mL, while the

Discussion

Elution method 2 comprises a simplified single elution step (excluding post-elution) and results in up to 95% of the total eluted activity available for labelling, although in a bigger volume than that obtained with method 1 or with more conventional fractionated elution procedures. Most available literature reports dealing with [68Ga]DOTA-peptide labelling describe the use of a TiO2-based generator, using eluates with relatively low acidity and small reaction volumes ranging between 100 μL and

Conclusions

Consistently high labelling efficiencies can be obtained in relatively large buffer-containing reaction mixtures, provided that at least 50 μg DOTATATE is used. Merely a single generator elution step is required, which makes the pre-concentration of eluates or the use of more conventional fractionation procedures unnecessary. This generator can still be used post 12 months up to approximately 18 months. After 18 months the generator still provides enough activity per elution to prepare purified [

Acknowledgement

The authors wish to thank S. Dolley of iThemba LABS for his assistance and advice with the 68Ge analysis of purified samples.

References (19)

There are more references available in the full text version of this article.

Cited by (17)

  • Production of medical isotope <sup>68</sup>Ge based on a novel chromatography separation technique and assembling of <sup>68</sup>Ge/<sup>68</sup>Ga generator

    2023, Applied Radiation and Isotopes
    Citation Excerpt :

    It is obvious that free 68Ga(III) transferred to the solvent front (Rf = 0.8-1.0) and 68Ga-DOTATATE stayed at the origin (Fig. 11A), which is similar with results reported in the literature (Tworowska et al., 2016). It was found that labelling efficiency of 68Ga with DOTATATE can retain >96%, which agrees well with that obtained in previous report (Rossouw and Breeman, 2012). With 68Ga-PSMA-617, the labelling complex held at the point of spotting and free 68Ga(III) migrated to the front of solvent (Fig. 11B).

  • Radiosynthesis of clinical doses of <sup>68</sup>Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based <sup>68</sup>Ge/<sup>68</sup>Ga generators

    2016, Nuclear Medicine and Biology
    Citation Excerpt :

    The values recorded within 10% of the known half-life were considered as acceptable for release of the dose. The pre-concentration of 68Ga was done using ion-exchange resins according to published protocols, which were modified slightly to accommodate the use of lower molarity of HCl [29–34]. To select the most appropriate separation method, we tested several anion-exchange (Bio-Rad AG1-X8, Wax Oasis Waters, Macherey-Nagel 30-PS-HCO3 Chromafix) and cation-exchange resin (Phenomenex Strata XC, Bio-Rad AG50W-X8) and determined their efficacy for 68Ga pre-concentration.

  • <sup>68</sup>Ga-DOTA and analogs: Current status and future perspectives

    2014, Reports of Practical Oncology and Radiotherapy
    Citation Excerpt :

    The gallium-68 eluted from the inorganic generator often suffered from the contamination by other metals, which influenced negatively radiolabelling.10 Commonly observed impurities are: Fe(III), Al(III) and Zn(II) at the mg/L levels, Ni(II), Co(II), Cd(II) and Cu(II) at 0.01–0.1 mg/L and traces of Mn, Pb, Cr, V.7,11 Average gallium-68 breakthrough varies from 10−4 to 10−5%. The most critical impurities are 68Ge, Fe(III), Zn(II), Mn(II), thus additional purification and removal of the metal contaminants has to be applied.

  • Peptide synthesis, characterization and <sup>68</sup>Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT

    2014, Nuclear Medicine and Biology
    Citation Excerpt :

    The concentration effect (achieved by full-scale elution of 68GaCl3 reduced from 0.84 ml instead of 7.5 ml) was comparable to similar procedures published by de Blois et al. [44]. During optimization of the 68Ga labeling for NOTA-conjugated peptides, both NOTA-conjugated peptides showed similar labeling efficiencies using 2.5 M sodium acetate as buffer as has been previously reported for DOTA conjugated peptides [17,18]. Using sodium acetate (2.5 M) as buffer, both NOTA-conjugated peptides were labeled at 50 °C to yield between 40 and 50% labeled product, however, optimal labeling efficiencies were achieved at 85 °C.

View all citing articles on Scopus
View full text